Can We Streamline How AAV Gene Therapies Are Developed?

  P.J. Brooks, PhD, Acting Director of the Office of Rare Diseases Research at the National Center for Advancing Translational Sciences (NCATS), describes the Platform Vector Gene Therapy (PaVe-GT) pilot project. As Dr. Brooks explains, adeno-associated virus...

Funding Opportunities for Desmoid Tumor Researchers  

  Jeanne Whiting, Co-Founder and Executive Director of the Desmoid Tumor Research Foundation, gives an overview of the foundation and how their work has benefited patients with these rare tumors. Desmoid tumors can grow anywhere on the body into surrounding...

The Pathophysiology of Spinal Muscular Atrophy (SMA)

The Pathophysiology of Spinal Muscular Atrophy (SMA)       Diana Castro, MD, founder of the Neurology Rare Disease Center in Dallas, Texas discusses the pathophysiology of spinal muscular atrophy (SMA). SMA is a rare inherited neuromuscular disorder caused...

Fabry Disease Treatment and Research Landscape

  Ankit Mehta, MD, Nephrologist and Program Director for the Department of Internal Medicine at Baylor University Medical Center, discusses the current treatment landscape for Fabry disease, including approved and investigational therapies. Fabry disease is a...